Trial intelligence / Profile preview

Weighted vs Uniform Tranexamic Acid in TKA

NCT01651806Phase 3Completed

Sponsor
Rush University Medical Center
Start
May 2012
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of tranexamic acid in intraoperative bleeding (5 arms), sponsored by Rush University Medical Center. Primary endpoints: Primary Intra-operative Blood Loss and Incidences of DVT and Other Thromboembolic Events at 1 year. Started May 2012; status: completed.

02

Drugs

tranexamic acid
03

Conditions

intraoperative bleeding

Beyond the preview

Go deeper on NCT01651806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01651806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call